Nadine Housri, MD, is a radiation oncologist with subspecialty expertise in stereotactic radiosurgery and radiotherapy. She serves as Associate Professor of Therapeutic Radiology at Yale School of Medicine and is the Co‑Founder and Chief Medical Officer of theMednet. Clinically, Dr. Housri focuses on thoracic radiation oncology, stereotactic radiosurgery and radiotherapy, and image‑guided precision treatments. Her research centers on normal tissue toxicity modeling in radiation therapy, outcomes research in thoracic radiation oncology, and equity and representation in oncology clinical trials. A recognized innovator, she received the Healio Disruptive Innovator Award in Clinical Innovation and leads theMednet as Co‑Founder and Chief Medical Officer. Dr. Housri earned her MD from the University of Miami Miller School of Medicine, completed residency in radiation oncology at Rutgers Robert Wood Johnson Medical School, and pursued fellowships in stereotactic radiosurgery and radiotherapy at Yale School of Medicine and in the Clinical Research Training Program at the National Institutes of Health.
Associate Professor
Medical School
2009
Residency
2010 – 2014
Fellowship
2014 – 2015